Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 26;11(11):1260.
doi: 10.3390/genes11111260.

5HTTLPR Genetic Variant and Major Depressive Disorder: A Review

Affiliations
Review

5HTTLPR Genetic Variant and Major Depressive Disorder: A Review

Caroline Fratelli et al. Genes (Basel). .

Abstract

Major Depressive Disorder (MDD) is a disease that involves biological, psychological, and social interactions. Studies have shown the importance of genetics contribution to MDD development. The SCL6A4 protein (5HTTLPR) functions transporting serotonin, a neurotransmitter linked to mood and emotion, to the synaptic cleft. Hence, this study seeks, through a literature review, a better comprehension of the 5HTTLPR genetic variant association with MDD. For this purpose, a search was performed on the Virtual Health Library Portal for articles that related 5HTTLPR to MDD. Most of the articles found were conducted in the American continent, with one (1) study implemented in Brazil. 5HTTLPR associations were found regarding changes in the nervous system, pharmacology, and risk factors seen in MDD patients. When verifying the allelic distribution, the S allele had a higher frequency in most of the studies analyzed. Despite not finding a commonality in the different studies, the tremendous genetic variation found demonstrates the MDD complexity. For this reason, further studies in diverse populations should be conducted to assist in the understanding and treatment of the disease.

Keywords: 5HTTLPR; genetic polymorphism; major depressive disorder; nervous system; pharmacogenomics; risk-factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Article selection flowchart.
Figure 2
Figure 2
Number of articles per continent.
Figure 3
Figure 3
Genotypic distribution according to the number of articles found.

References

    1. World Health Organization . World Heal Organization; 2017. [(accessed on 1 October 2020)]. Depression and Other Common Mental Disorders: Global Health Estimates. Available online: https://apps.who.int/iris/bitstream/handle/10665/254610/WHO-MSD-MER-2017....
    1. Iancu S.C., Wong Y.M., Rhebergen D., Van Balkom A.J.L.M., Batelaan N.M. Long-term disability in major depressive disorder: A 6-year follow-up study. Psychol. Med. 2019;50:1644–1652. doi: 10.1017/S0033291719001612. - DOI - PubMed
    1. Ferrari A.J., Charlson F.J., Norman R.E., Patten S.B., Freedman G.D., Murray C.J., Vos T., Whiteford H.A. Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010. PLoS Med. 2013;10:e1001547. doi: 10.1371/journal.pmed.1001547. - DOI - PMC - PubMed
    1. Wang H., Naghavi M., Allen C., Barber R.M., Bhutta Z.A., Carter A., Casey D.C., Charlson F.J., Chen A.Z., Coates M.M., et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–1544. doi: 10.1016/S0140-6736(16)31012-1. - DOI - PMC - PubMed
    1. Flint J., Kendler K.S. The Genetics of Major Depression. Neuron. 2014;81:484–503. doi: 10.1016/j.neuron.2014.01.027. - DOI - PMC - PubMed

Publication types

LinkOut - more resources